These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
578 related articles for article (PubMed ID: 28760771)
1. Diabetic nephropathy - is this an immune disorder? Tesch GH Clin Sci (Lond); 2017 Aug; 131(16):2183-2199. PubMed ID: 28760771 [TBL] [Abstract][Full Text] [Related]
2. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy. Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569 [TBL] [Abstract][Full Text] [Related]
3. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy. Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678 [TBL] [Abstract][Full Text] [Related]
4. Role of Immune Cells in Diabetic Kidney Disease. Yang X; Mou S Curr Gene Ther; 2017; 17(6):424-433. PubMed ID: 29446740 [TBL] [Abstract][Full Text] [Related]
5. Innate immunity in diabetes and diabetic nephropathy. Wada J; Makino H Nat Rev Nephrol; 2016 Jan; 12(1):13-26. PubMed ID: 26568190 [TBL] [Abstract][Full Text] [Related]
6. Role of heparanase-driven inflammatory cascade in pathogenesis of diabetic nephropathy. Goldberg R; Rubinstein AM; Gil N; Hermano E; Li JP; van der Vlag J; Atzmon R; Meirovitz A; Elkin M Diabetes; 2014 Dec; 63(12):4302-13. PubMed ID: 25008182 [TBL] [Abstract][Full Text] [Related]
7. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Elmarakby AA; Sullivan JC Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759 [TBL] [Abstract][Full Text] [Related]
8. Immune Cells and Inflammation in Diabetic Nephropathy. Zheng Z; Zheng F J Diabetes Res; 2016; 2016():1841690. PubMed ID: 26824038 [TBL] [Abstract][Full Text] [Related]
9. The role of IL-18 in type 1 diabetic nephropathy: The problem and future treatment. Elsherbiny NM; Al-Gayyar MM Cytokine; 2016 May; 81():15-22. PubMed ID: 26836949 [TBL] [Abstract][Full Text] [Related]
10. Leukocyte recruitment and vascular injury in diabetic nephropathy. Galkina E; Ley K J Am Soc Nephrol; 2006 Feb; 17(2):368-77. PubMed ID: 16394109 [TBL] [Abstract][Full Text] [Related]
11. Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy. Navarro JF; Mora C ScientificWorldJournal; 2006 Aug; 6():908-17. PubMed ID: 16906324 [TBL] [Abstract][Full Text] [Related]
12. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Chow F; Ozols E; Nikolic-Paterson DJ; Atkins RC; Tesch GH Kidney Int; 2004 Jan; 65(1):116-28. PubMed ID: 14675042 [TBL] [Abstract][Full Text] [Related]
13. Toll-like receptors: sensing and reacting to diabetic injury in the kidney. Lin M; Tang SC Nephrol Dial Transplant; 2014 Apr; 29(4):746-54. PubMed ID: 24203812 [TBL] [Abstract][Full Text] [Related]
14. Inflammation and the pathogenesis of diabetic nephropathy. Wada J; Makino H Clin Sci (Lond); 2013 Feb; 124(3):139-52. PubMed ID: 23075333 [TBL] [Abstract][Full Text] [Related]
15. Loganin attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products. Liu K; Xu H; Lv G; Liu B; Lee MK; Lu C; Lv X; Wu Y Life Sci; 2015 Feb; 123():78-85. PubMed ID: 25623853 [TBL] [Abstract][Full Text] [Related]
16. Diabetic kidney disease and immune modulation. Hickey FB; Martin F Curr Opin Pharmacol; 2013 Aug; 13(4):602-12. PubMed ID: 23721739 [TBL] [Abstract][Full Text] [Related]
20. Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Rivero A; Mora C; Muros M; García J; Herrera H; Navarro-González JF Clin Sci (Lond); 2009 Mar; 116(6):479-92. PubMed ID: 19200057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]